Development of a Model Care Pathway for Myasthenia Gravis.

Payedimarri, Anil Babu; Ratti, Matteo; Rescinito, Riccardo; Vasile, Alessandra; Seys, Deborah; Dumas, Hervé; Vanhaecht, Kris; Panella, Massimiliano

Payedimarri, Anil Babu; Ratti, Matteo; Rescinito, Riccardo; Vasile, Alessandra; Seys, Deborah; Dumas, Hervé; Vanhaecht, Kris; Panella, Massimiliano.

Afiliação

Payedimarri AB; Department of Translational Medicine (DIMET), Università del Piemonte Orientale, 28100 Novara, Italy.
Ratti M; European Pathway Association, 3000 Leuven, Belgium.
Rescinito R; Department of Translational Medicine (DIMET), Università del Piemonte Orientale, 28100 Novara, Italy.
Vasile A; European Pathway Association, 3000 Leuven, Belgium.
Seys D; Department of Translational Medicine (DIMET), Università del Piemonte Orientale, 28100 Novara, Italy.
Dumas H; European Pathway Association, 3000 Leuven, Belgium.
Vanhaecht K; Department of Translational Medicine (DIMET), Università del Piemonte Orientale, 28100 Novara, Italy.
Panella M; European Pathway Association, 3000 Leuven, Belgium.

Int J Environ Res Public Health ; 18(21)2021 11 04.

Article em En | MEDLINE | ID: mdl-34770107

Assuntos

Miastenia Gravis; Humanos; Miastenia Gravis/diagnóstico; Miastenia Gravis/terapia

Palavras-chave

care pathway; clinical pathway; core activities; critical pathway; integrated care pathway; key interventions; model pathway; myasthenia gravis; process flow; quality indicators

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google